US Patent 7351707 Spiroazacyclic compounds as monoamine receptor modulators

Patent 7351707 was granted and assigned to Acadia Pharmaceuticals on April, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Acadia Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7351707

Date of Patent

April 1, 2008

Patent Application Number

11418322

Date Filed

May 3, 2006

Patent Citations Received

‌

US Patent 11840515 Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form c

Patent Primary Examiner

‌

Kahsay Habte

Patent abstract

The present invention relates to optionally substituted 1-oxa-4,9-diaza-spiro[5.5]undecan-3-one compounds as monoamine receptor modulators; compositions comprising the same; methods of inhibiting an activity of a monoamine receptor with said compounds; methods of treating a disease condition associated with a monoamine receptor using said compounds; and methods for identifying a subject suitable for treatment using said compounds.